Acute DOB and PMA Administration Impairs Motor and Sensorimotor Responses in Mice and Causes Hallucinogenic Effects in Adult Zebrafish.
DOB
PMA
hallucinogens
mice
prepulse inhibition
sensorimotor responses
zebrafish
Journal
Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646
Informations de publication
Date de publication:
24 Aug 2020
24 Aug 2020
Historique:
received:
23
07
2020
revised:
14
08
2020
accepted:
20
08
2020
entrez:
28
8
2020
pubmed:
28
8
2020
medline:
28
8
2020
Statut:
epublish
Résumé
The drastic increase in hallucinogenic compounds in illicit drug markets of new psychoactive substances (NPS) is a worldwide threat. Among these, 2, 5-dimetoxy-4-bromo-amphetamine (DOB) and paramethoxyamphetamine (PMA; marketed as "ecstasy") are frequently purchased on the dark web and consumed for recreational purposes during rave/dance parties. In fact, these two substances seem to induce the same effects as MDMA, which could be due to their structural similarities. According to users, DOB and PMA share the same euphoric effects: increasing of the mental state, increasing sociability and empathy. Users also experienced loss of memory, temporal distortion, and paranoia following the repetition of the same thought. The aim of this study was to investigate the effect of the acute systemic administration of DOB and PMA (0.01-30 mg/kg; i.p.) on motor, sensorimotor (visual, acoustic, and tactile), and startle/PPI responses in CD-1 male mice. Moreover, the pro-psychedelic effect of DOB (0.075-2 mg/kg) and PMA (0.0005-0.5 mg/kg) was investigated by using zebrafish as a model. DOB and PMA administration affected spontaneous locomotion and impaired behaviors and startle/PPI responses in mice. In addition, the two compounds promoted hallucinatory states in zebrafish by reducing the hallucinatory score and swimming activity in hallucinogen-like states.
Identifiants
pubmed: 32847111
pii: brainsci10090586
doi: 10.3390/brainsci10090586
pmc: PMC7563198
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Drug Policies Department, Presidency of the Council of Ministers, Italy
ID : project: "Effects of NPS: development of a multicentric research for the information enhancement of the Early Warning System"
Organisme : local funds from the University of Ferrara
ID : FAR 2019 and FAR 2020
Organisme : Zardi-Gori Foundation
ID : (Funding 2018-2019)
Références
J Med Chem. 1997 Sep 12;40(19):2997-3008
pubmed: 9301661
Neurotoxicology. 2020 Jan;76:17-32
pubmed: 31610187
Neuropharmacology. 2020 Jul;171:108110
pubmed: 32344007
Leg Med (Tokyo). 2003 Mar;5 Suppl 1:S138-41
pubmed: 12935573
Eur J Pharmacol. 1974 Feb;25(2):176-84
pubmed: 4435021
J Anal Toxicol. 1998 Mar-Apr;22(2):169-72
pubmed: 9547415
ACS Chem Neurosci. 2013 Aug 21;4(8):1137-50
pubmed: 23883191
Biochem Pharmacol. 1971 Mar;20(3):693-706
pubmed: 5150164
Life Sci I. 1971 Oct 1;10(19):1087-95
pubmed: 5132700
Int J Neuropsychopharmacol. 2018 Oct 1;21(10):926-931
pubmed: 29850881
Clin Toxicol (Phila). 2012 Jan;50(1):39-43
pubmed: 22148985
Neuropharmacology. 2015 Aug;95:68-82
pubmed: 25769232
Psychopharmacology (Berl). 2016 Aug;233(15-16):3031-9
pubmed: 27318987
Brain Res. 1991 Aug 23;557(1-2):190-201
pubmed: 1747753
Curr Top Behav Neurosci. 2018;36:159-199
pubmed: 28224459
Eur Neuropsychopharmacol. 2014 Aug;24(8):1362-70
pubmed: 24862256
Psychopharmacology (Berl). 2014 Dec;231(24):4681-93
pubmed: 24862365
Neuroscience. 2015 Aug 6;300:174-88
pubmed: 25987201
World Psychiatry. 2015 Feb;14(1):15-26
pubmed: 25655145
Pharmacol Biochem Behav. 1988 Sep;31(1):9-13
pubmed: 3252264
J Neurosci. 2013 Jun 19;33(25):10544-51
pubmed: 23785166
J Med Chem. 1982 May;25(5):530-5
pubmed: 7086839
Naunyn Schmiedebergs Arch Pharmacol. 1999 Jan;359(1):1-6
pubmed: 9933142
Biochem Pharmacol. 1997 Dec 15;54(12):1361-9
pubmed: 9393679
Tidsskr Nor Laegeforen. 2013 May 7;133(9):966-9
pubmed: 23652145
Neuropharmacology. 2019 Jan;144:368-376
pubmed: 30385253
Pharmacol Biochem Behav. 2011 Mar;98(1):130-9
pubmed: 21167195
Brain Res. 1979 Jan 26;161(1):167-72
pubmed: 758967
Int J Legal Med. 2020 Sep;134(5):1695-1711
pubmed: 32356113
Neuropsychopharmacology. 2009 Jul;34(8):1958-67
pubmed: 19322172
Cell Rep. 2019 Mar 26;26(13):3475-3483.e4
pubmed: 30917304
Front Pharmacol. 2019 Dec 12;10:1406
pubmed: 31915427
J Anal Toxicol. 2003 May-Jun;27(4):253-6
pubmed: 12820749
Brain Res. 1997 Jun 27;761(1):97-104
pubmed: 9247071
J Pharmacol Exp Ther. 1974 Jun;189(3):717-24
pubmed: 4858403
Clin Toxicol (Phila). 2011 Oct;49(8):705-19
pubmed: 21970769
J Med Chem. 1991 Jan;34(1):276-81
pubmed: 1992127
J Pharmacol Exp Ther. 1976 May;197(2):272-9
pubmed: 946817
Peptides. 2012 Oct;37(2):327-33
pubmed: 22828174
Forensic Sci Int. 2005 Oct 4;153(1):85-91
pubmed: 15979834
Drug Test Anal. 2012 Jul-Aug;4(7-8):556-76
pubmed: 22517680
Neuropsychopharmacology. 2006 Mar;31(3):506-15
pubmed: 16123772
Biochem Pharmacol. 2018 Dec;158:27-34
pubmed: 30261175
Brain Res. 1980 Oct 27;200(1):105-21
pubmed: 6106524
Psychopharmacology (Berl). 2007 Mar;190(4):441-8
pubmed: 17219220
Neuropharmacology. 2018 Nov;142:240-250
pubmed: 29501528
Transl Psychiatry. 2011 Aug 16;1:e33
pubmed: 22832607
J Neurophysiol. 2006 Nov;96(5):2177-88
pubmed: 16870843
Brain Res. 2005 Apr 11;1041(1):48-55
pubmed: 15804499
Forensic Sci Int. 2016 Apr;261:137-47
pubmed: 26930544
Hear Res. 2016 Feb;332:121-136
pubmed: 26688176
Front Integr Neurosci. 2011 Aug 18;5:40
pubmed: 21887133
Behav Brain Res. 2016 Nov 1;314:181-9
pubmed: 27506653
Leg Med (Tokyo). 2015 Jan;17(1):56-9
pubmed: 25248801
J Psychopharmacol. 2014 Aug;28(8):780-8
pubmed: 24569095
Hear Res. 2017 Feb;344:13-23
pubmed: 27838373
J Neurosci. 1999 Sep 15;19(18):8071-82
pubmed: 10479707
Cereb Cortex. 2009 Aug;19(8):1915-28
pubmed: 19056862
Arch Toxicol. 2020 Apr;94(4):1085-1133
pubmed: 32249347
Neurotox Res. 2016 Apr;29(3):394-407
pubmed: 26501352
Exp Brain Res. 1977 Jan 18;27(1):71-80
pubmed: 832690
Neuropharmacology. 2018 Oct;141:167-180
pubmed: 30165078
Neuropharmacology. 2014 Apr;79:152-60
pubmed: 24275046
Neuropharmacology. 2020 May 1;167:107933
pubmed: 31917152
Prog Neuropsychopharmacol Biol Psychiatry. 2000 Aug;24(6):955-77
pubmed: 11041537
CNS Neurosci Ther. 2008 Winter;14(4):295-314
pubmed: 19040555
Mol Pharmacol. 1995 Mar;47(3):544-50
pubmed: 7700252
Neuropharmacology. 2013 Jul;70:218-27
pubmed: 23376711
J Neurophysiol. 2001 Feb;85(2):828-42
pubmed: 11160516